Overview |
bs-0271R-FITC |
Cytomegalovirus pp65 Antibody, FITC Conjugated |
WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
Human, Mouse, Bovine, Virus |
Specifications |
FITC |
Rabbit |
KLH conjugated synthetic peptide derived from Cytomegalovirus pp65 |
251-350/561 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
3077579 |
Q6SW59 |
65 kDa phosphoprotein; pp65; 65 kDa matrix phosphoprotein; Phosphoprotein UL83; Tegument protein UL83; UL83 |
Counteracts the host antiviral immune response by preventing IRF3 from entering the nucleus once activated and phosphorylated. Participates also in the transactivation of viral major immediate-early genes by recruiting host IFI16 to their promoters. |
Application Dilution |
WB |
1:300-5000 |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |